Next, we performed staining for CD31 and LYVE-1 to study tumor invasion into the vein and lymph vessels, respectively (Fig. 2g), because invasion of PDAC cells was inhibited by CXCR2 inhibitor in vitro. This evidence concerns the gene CXCR2 and neoplasm.